Methyldopa
Generic Details
Generic Name
Methyldopa
Other Names
- Aldomet
Drug Class
- Antihypertensive
Chemical Formula
C10H13NO4
Molecular Weight
211.216 g/mol
Mechanism of Action
- Methyldopa is a prodrug that is metabolized to alpha-methyl norepinephrine, which acts centrally to reduce sympathetic outflow, leading to decreased peripheral resistance and a subsequent decrease in blood pressure.
Indications
- Hypertension
Common Dosage Forms
- Tablet
- Injection
Typical Dosage
- 250-500 mg 2-4 times per day
Pediatric Dosage
- Dosage for children should be calculated based on body weight and under the supervision of a healthcare provider.
Geriatric Dosage
- Dosage adjustments may be necessary in elderly patients due to age-related changes in drug metabolism.
Side Effects
- Drowsiness
- Orthostatic hypotension
- Dry mouth
- Nausea
- Headache
Contraindications
- Hypersensitivity to methyldopa
- Active hepatic disease
Pregnancy Category
- Category B - No evidence of risk in humans
Lactation Safety
- Safe to use while breastfeeding with monitoring for potential side effects in the infant
Drug Interactions
- Monoamine oxidase inhibitors (MAOIs) may potentiate the hypotensive effect of methyldopa
Overdose Symptoms
- Severe hypotension
- Bradycardia
- CNS depression
Antidote for Overdose
- Supportive care, monitoring, and symptomatic treatment
Storage Conditions
- Store at room temperature away from moisture and heat.
Pharmacokinetics
- Absorption: Well absorbed from the gastrointestinal tract
- Distribution: Crosses the blood-brain barrier and placenta; distributes into breast milk
- Metabolism: Metabolized to alpha-methyl norepinephrine
- Excretion: Primarily renal excretion
Precautions
- Caution in patients with a history of depression or psychiatric disorders
Warnings
- Abrupt withdrawal can lead to rebound hypertension
Others
- Methyldopa may cause a positive Coombs test result.